Tiebo Mao

State Key Laboratory Of Systems Medicine For Cancer Of Oncology Department And Shanghai Cancer Institute
Shanghai, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications

CREB3L1 facilitates pancreatic tumor progression and reprograms intratumoral tumor-associated macrophages to shape an immunotherapy-resistance microenvironment.

CREB3L1 facilitates pancreatic tumor progression and reprograms intratumoral tumor-associated macrophages to shape an immunotherapy-resistance microenvironment.

Journal: Journal for immunotherapy of cancer
Published: December 12, 2024

Targeting pancreatic cancer glutamine dependency confers vulnerability to GPX4-dependent ferroptosis.

Targeting pancreatic cancer glutamine dependency confers vulnerability to GPX4-dependent ferroptosis.

Journal: Cell reports. Medicine
Published: January 30, 2024

Activation of the PI3K/AKT signaling pathway by ARNTL2 enhances cellular glycolysis and sensitizes pancreatic adenocarcinoma to erlotinib.

Activation of the PI3K/AKT signaling pathway by ARNTL2 enhances cellular glycolysis and sensitizes pancreatic adenocarcinoma to erlotinib.

Journal: Molecular cancer
Published: November 16, 2023

The Role of Bile Acids in Pancreatic Cancer.

The Role of Bile Acids in Pancreatic Cancer.

Journal: Current cancer drug targets
Published: September 07, 2023

PLA2G2A+ cancer-associated fibroblasts mediate pancreatic cancer immune escape via impeding antitumor immune response of CD8+ cytotoxic T cells.

PLA2G2A+ cancer-associated fibroblasts mediate pancreatic cancer immune escape via impeding antitumor immune response of CD8+ cytotoxic T cells.

Journal: Cancer letters
Published: December 05, 2022

Chemotherapeutic drugs-induced pyroptosis mediated by gasdermin E promotes the progression and chemoresistance of pancreatic cancer.

Chemotherapeutic drugs-induced pyroptosis mediated by gasdermin E promotes the progression and chemoresistance of pancreatic cancer.

Journal: Cancer letters
Published: November 23, 2022

Cuproptosis-related lncRNAs are correlated with tumour metabolism and immune microenvironment and predict prognosis in pancreatic cancer patients.

Cuproptosis-related lncRNAs are correlated with tumour metabolism and immune microenvironment and predict prognosis in pancreatic cancer patients.

Journal: IET systems biology
Published: November 10, 2022

A Novel Molecular Signature of Cancer-Associated Fibroblasts Predicts Prognosis and Immunotherapy Response in Pancreatic Cancer.

A Novel Molecular Signature of Cancer-Associated Fibroblasts Predicts Prognosis and Immunotherapy Response in Pancreatic Cancer.

Journal: International journal of molecular sciences
Published: October 27, 2022

HDACs/mTOR inhibitor synergizes with pyrotinib in HER2-positive pancreatic cancer through degradation of mutant P53.

HDACs/mTOR inhibitor synergizes with pyrotinib in HER2-positive pancreatic cancer through degradation of mutant P53.

Journal: Cancer cell international
Published: October 07, 2022

A novel angiogenesis-based molecular signature related to prognosis and tumor immune interactions of pancreatic cancer.

A novel angiogenesis-based molecular signature related to prognosis and tumor immune interactions of pancreatic cancer.

Journal: Frontiers in cell and developmental biology
Published: July 23, 2022

Prediction of Survival and Tumor Microenvironment Infiltration Based on Pyroptosis-Related lncRNAs in Pancreatic Cancer.

Prediction of Survival and Tumor Microenvironment Infiltration Based on Pyroptosis-Related lncRNAs in Pancreatic Cancer.

Journal: Disease markers
Published: July 10, 2022

Association of aging-related genes with prognosis and immune infiltration in pancreatic adenocarcinoma.

Association of aging-related genes with prognosis and immune infiltration in pancreatic adenocarcinoma.

Journal: Frontiers in cell and developmental biology
Published: May 12, 2022
Showing 1-12 of 21

Last Updated: 09/26/2026